New Age Metals is conducting a basal till sampling program on its Sentinel gold-antimony property in Newfoundland, targeting a large geophysical conductor along the same structural corridor as the past-producing Beaver Brook Antimony Mine. The program aims to detect concealed gold and antimony mineralization beneath thick glacial cover using about 250 samples. Supported by local contractors and government funding, this exploration could identify new mineral targets in a historically productive region. Results will be reported after analysis and verification.
New Age Metals' basal till sampling program at the Sentinel gold-antimony project provides context for readers following Basic Materials. For readers following Basic Materials, here is Pluang's market snapshot as of Nov 10, 2026 18:41 WIB: Of 83 priced Basic Materials-sector US stocks tradable on Pluang, 26 rose and 54 fell today. Notable movers include HMY (Harmony Gold Mining Co.) at USD 17.02 with a 1-day change of -3.30% and Pluang order activity showing 86% Sell / 14% Buy, USAS (Americas Gold and Silver Corporation) at USD 3.19 down 3.04%, and HYMC (Hycroft Mining Holding Corporation) at USD 20.64 down 2.96% with balanced Pluang order activity of 50% Sell / 50% Buy.
The 2026 Verizon Data Breach Investigations Report links 61% of manufacturing breaches to third parties and 81% to internal data compromise. Manufacturers adopting Microsoft 365 Copilot should carefully manage which engineering and supplier files emp...
Soleo Health has been selected as a specialty pharmacy partner for Pasatru™ (garetosmab-grts), Regeneron's FDA-approved treatment for adults with fibrodysplasia ossificans progressiva (FOP), an ultra-rare genetic disorder. Pasatru™ is the first treat...
PsiThera raised $25 million in financing led by new investors AbbVie Ventures and Lumination Capital, alongside existing backers. The funds will support development of its oral small molecule TNFα inhibitor and advance its oral TL1A inhibitors into l...
Opus Genetics announced its Q3 2026 financial results and significant progress in its gene therapy programs for inherited retinal diseases. Key milestones include completion of dosing in OPGx-BEST1 Cohort 2 with data expected in Q1 2027, full enrollm...
Iveco Group is exhibiting its latest products, including new light and heavy-duty vehicles powered by FPT engines, at Fenatran 2026 in São Paulo, highlighting its strong industrial and commercial presence in Latin America. The event marks the regiona...
